Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07398170 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study

Name: Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study — clinical trial record (NCT07398170)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BIOLIMEN-1

StatusRecruiting

PhaseNot applicable

SponsorUniversity Hospital, Montpellier

Started2026-07-13

View on ClinicalTrials.gov ↗

Trial flagged as At Risk

Primary completion moved at least 2 months later Jul 2027 → Oct 2027

See other at-risk trials from University Hospital, Montpellier

Amendment history

2026-07-13

Study Status, Contacts/Locations v1

Recruitment opened

Primary completion pushed: 2027-07 → 2027-10

Completion pushed: 2027-07 → 2027-10

Start dateestimated 2026-03→confirmed 2026-07-13

Study sitesdetails revised at 1 of 1 site

2026-02-02

Original filing

University Hospital, Montpellier

303 trials monitored

See 6 trials at risk

The goal of the clinical trial is to assess the presence of circulating tumor cells (CTCs) in the blood and/or cerebrospinal fluid (CSF) of patients with aggressive recurrent meningiomas.

Trial Details

NCT Number	NCT07398170
Lead Sponsor	University Hospital, Montpellier
Conditions	Meningioma
Enrollment	15 participants
Start Date	2026-07-13
Primary Completion	2027-10 (estimated)
Study Completion	2027-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-14